Dermatomyositis
📧 Sign up to get email alerts when something new happens for Dermatomyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study [Phase 2]
A Phase 2 pilot study evaluating subcutaneous sodium thiosulfate for ectopic calcifications associated with systemic sclerosis and dermatomy…
-
CLINICAL_TRIALS other · 2025-03-25Clinical Trial Update: Study of NM8074 in Patients with Dermatomyositis (DM) [Phase 2]
This is an update on a Phase 2 clinical trial evaluating NM8074 for dermatomyositis, currently not recruiting.
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial updates describe infusion of mesenchymal stem cells in multiple autoimmune diseases and indicate the …
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Interest of LC-OCT for Diagnosing Inflammatory Dermatoses: ODIN (OCT Dermotoses INflammatoires)
ODIN is a completed clinical trial evaluating the use of LC-OCT to diagnose inflammatory dermatoses, assessing its potential diagnostic valu…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Evaluation of Tp-e Interval and Tp-e/QT Ratio in Dermatomyositis and Analysis of Their Relationship With Inflammation
The trial evaluated Tp-e interval and Tp-e/QT ratio in patients with dermatomyositis. It analyzed their relationship with inflammation and m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Biomarkers of Cancer-Associated Myositis
Clinical trial update on biomarkers of cancer-associated myositis in dermatomyositis; the study is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study [Phase 2]
An extension study for participants who completed the treatment period of a qualifying Phase 2 parent study in dermatomyositis has completed…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM) [EARLY_Phase 1]
A Phase 1 study evaluating ULSC in patients with polymyositis and dermatomyositis has completed.
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases [NA]
A recruiting clinical trial evaluating home-based clinical management for interstitial lung disease with progressive fibrosing phenotype in …
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases [Phase 1]
Amgen reported completion of a Phase 1 study of MEDI7734 in Type I interferon-mediated autoimmune diseases, including dermatomyositis, polym…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis [Phase 1]
Amgen's Phase 1 study evaluating VIB7734 in multiple autoimmune diseases including systemic lupus erythematosus, cutaneous lupus erythematos…
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis [Phase 2, Phase 3]
Phase 2/3 trial of ravulizumab versus placebo in adults with dermatomyositis was terminated, and results have been posted.
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Rheumatology Diet Study
A rheumatology dietary intervention study sponsored by the University of Central Florida is currently recruiting, listing multiple autoimmun…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Evaluation of Patients With Refractory Dermatomyositis Using [18F] FAPI-74 PET/MRI Imaging [Phase 2]
Phase 2 trial evaluating the PET/MRI tracer [18F] FAPI-74 for imaging in patients with refractory dermatomyositis; the study is currently NO…
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM) [Phase 1]
A Phase 1 trial is evaluating a CD19-targeted universal CAR-T therapy (UCAR-T) for refractory juvenile dermatomyositis and is currently recr…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
This clinical trial update describes a study to identify cutaneous and blood biomarkers that predict response to systemic treatments across …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Exercise Capacity of Patients with Dermatomyosis [NA]
This entry notes that a clinical trial examining exercise capacity in patients with dermatomyositis has been terminated at University Hospit…
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis
A clinical trial is currently recruiting to evaluate severity in juvenile- and adult-onset dermatomyositis.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis
A clinical trial is recruiting to investigate neutrophil extracellular traps in systemic sclerosis and related connective tissue diseases, s…
-
CLINICAL_TRIALS trial_result · 2024-06-11Clinical Trial Update: Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis [Phase 4]
A Phase 4 clinical trial update reports on the efficacy and safety of Acthar Gel (repository corticotropin injection) for refractory cutaneo…
-
CLINICAL_TRIALS trial_result · 2024-06-05Clinical Trial Update: Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM. [Phase 2]
Open-label extension results from the Phase 2 PRESIDIO crossover study evaluating KZR-616 in polymyositis and dermatomyositis have been comp…
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: 3T Therapy in the Treatment of MDA5-positive Dermatomyositis [Phase 4]
The document reports an ongoing Phase 4 clinical trial evaluating 3T Therapy for MDA5-positive Dermatomyositis, with enrollment by invitatio…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments [Phase 3]
Phase 3 trial of ustekinumab in active polymyositis and dermatomyositis was terminated, with results posted on May 13, 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis [Phase 1, Phase 2]
Clinical trial updates on allogeneic mitochondria (PN-101) transplantation for refractory polymyositis or dermatomyositis have completed Pha…
-
CLINICAL_TRIALS trial_result · 2024-02-26Clinical Trial Update: Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis [Phase 2, Phase 3]
Clinical trial update reporting results for sodium thiosulfate in calcinosis associated with dermatomyositis, with Phase 2 and Phase 3 studi…